Latest Director Resignation News

TerraCom Limited announces the resignation of Managing Director Danny McCarthy effective 30 April 2026, with Chris Bourke appointed as interim CEO. McCarthy will support the transition until September 2026, while the Board confirms no changes to operational or strategic priorities.

NeuRizer Limited has secured a pivotal partnership with Reliance Industries, enabling it to resolve funding challenges and accelerate its Leigh Creek urea project. This collaboration marks a turning point for the company, allowing it to exit suspension and advance critical regulatory and operational milestones.

Bougainville Copper Limited reported a preliminary net loss of K16 million for 2025, with no dividend declared. The company faces strategic uncertainty following a shareholder dispute over its preferred mining partner and the passing of its CEO.

Energy Technologies Limited reported a $5.63 million net loss for the half-year ending December 2025, with revenue down 53% as the company restructures and refocuses on renewable energy markets. Significant debt refinancing and board changes mark a critical phase for the industrial cable manufacturer.

Papyrus Australia Limited reported a reduced half-year loss and marked a significant commercial milestone with a $4.2 million supply contract, advancing its transition from technology development to early-stage commercialisation.

WA Kaolin reported $2.7 million in sales for the December quarter, secured a $1.5 million working capital loan, and restructured $20.4 million of debt, while focusing on plant improvements and cost reductions to address negative margins.

Nyrada Inc. reported a $3.19 million loss for the half-year ending December 2025, while advancing its lead drug candidate Xolatryp® into Phase IIa clinical trials targeting heart attack treatment.

Touch Ventures Limited reported a $4.6 million net loss for 2025, driven by investment impairments and foreign exchange impacts, while appointing Gannet Capital as its new investment manager to revamp its portfolio strategy.

Invex Therapeutics reports a net loss of $715,582 for H1 2026 while advancing its Exenatide program targeting neurological diseases, alongside notable board reshuffles.

Arcadia Minerals has entered a pivotal phase with a pending earn-in agreement on its Swanson Tantalum Project and a binding farm-in deal for its Karibib Copper-Gold Project, alongside strategic leadership changes and a planned capital raising.

Eastern Resources Limited reports steady progress on its Marengo Gold Project farm-in agreement despite ministerial approval delays, alongside ongoing environmental assessments at Nowa Nowa and a director resignation.

Swoop Holdings reports a robust 53% increase in customer receipts for the first half of FY26, driven by NBN and Mobile growth, while investing heavily in technology and launching a strategic refocus.